Published on 26/09/2025 09:07 AM
Paras Defence & Space Technologies has secured an order valued at $3.8 million.
Siddhartha Khemka, Head-Research, Wealth Management at Motilal Oswal Financial Services, on Tata Motors: “We have been a bit underweight quite some time. Since the last two quarters, we have downgraded the stock to neutral. And what we see is that JLR continue to face several headwinds, tariff wars, US depreciation versus some of the other currencies, and uncertainty over the EV transition. I think all those things continue. On top of it, the strong competition from some of these Chinese players in other regions so we believe that near-term earnings could remain under pressure. We have cut our FY26 estimates in the last two quarters. And we believe that given the multiple headwinds, we continue to remain underweight on Tata Motors, best avoided in the current environment.”
Rupee opens at 88.69/$ vs Thursday’s close of 88.67/$
L&T Technology has partnered with Siemens to drive AI-based transformation in process engineering and smart manufacturing.
Shares of Sun Pharmaceutical Industries, India’s largest drug maker, will be under the spotlight on Friday, September 26, following US President Donald Trump’s announcement of a 100% tariff on branded and patented drugs imported into the US, effective October 1.
Read Full Article#StocksToWatch | Here’s a list of stocks that are in focus going into trade today????
????Ventive: Proposes to acquire a 76% stake in Soham Leisure for an EV of approx ₹320 cr
Here’s more???? pic.twitter.com/rjI3luCyzm
— CNBC-TV18 (@CNBCTV18Live) September 26, 2025
US tariffs on branded pharmaceutical products may impact Sun Pharma and Wockhardt. Around 20% of Sun Pharma’s FY25 revenue came from speciality products, with 70–80% of that from the US.
The “branded” category may include some biosimilars, putting Biocon at potential risk, according to Aditya Khemka of InCred Asset Management.
Vodafone Idea shares are under the spotlight on Friday, September 26, as the Supreme Court is scheduled to hear the telecom company’s plea against the Centre’s AGR demand.
Read Full Article
Silver In Focus
Silver in 2025 : $ per ounce
Precious metals in 2025:
India restricts Silver Jewellery imports : With following HSN codes
71131141
71131149
India imports of silver Jew from Thailand : April -July
2024 : 87.6 tons
2025 : 361.8 tons
Citi on Nuvama
Here’s how the global market cues are placed this morning
UBS On APL Apollo Tubes
Citi On ICICI BK
Aditya Khemka of Incred Asset Management
SUN PHARMA
SUN PHARMA in Focus
Other stocks – DRL, Lupin, Torrent, Glenmark
Generic pharma stocks not impacted by news
Pharma stocks are likely to be under pressure due to the fear of further steps on pharma by the Trump Administration
CLSA on Asian Paints
Seshaasai Technologies will finalise the allotment of its ₹813.07-crore IPO on Friday, September 26.
The IPO, which opened on September 23 and closed on September 25, included a fresh issue of 1.13 crore shares worth ₹480 crore and an offer-for-sale of 79 lakh shares totalling ₹333.07 crore.
Read Full Article
Indian pharmaceutical firms, including Sun Pharma, Aurobindo Pharma, Gland Pharma, Lupin, and Cipla, will be under the spotlight on Friday, September 26, following US President Donald Trump’s announcement of 100% tariffs on branded and patented drugs, effective from October 1.
Read Full Article
CITI on IT
Anand Rathi Share & Stock Brokers is set to finalise the allotment of its ₹745 crore IPO on Thursday, September 26.
The book-built issue includes a fresh offer of 1.80 crore shares, with bidding open from September 23 to September 25.
Read Full Article
Nomura on Titan
Nomura on HAL
Morgan Stanley on HAL
Ather Energy
The US economy expanded more quickly than initially estimated in Q2, with revised figures highlighting its resilience despite challenges from trade policies and slowing global growth.
Read Full Article
Supreme Petrochem has commissioned an Acrylonitrile Butadiene Styrene (ABS) project with a capacity of 70,000 tonne per annum (TPA) at its Maharashtra plant.
Read Full Article
Mahindra and Mahindra (M&M) is set to release its results for the July to September quarter of 2025 (Q2FY26) on November 4.
TRADE SET UP
Cash flows on Sep 25, 2025
FII Net Sell ₹4,995 Cr
DII Net Buy ₹5,103 Cr
FIIs IN INDEX FUTURES
Contracts Change in OI Positioning
Longs +3,894 16%
Shorts +6481 84%
FII Writing Index Options (contracts)
Calls +102342
Puts +69860
OPTION CUES
Nifty PCR at 0.68 Vs 0.87
NIFTY OPTIONS (Sep 30)
Strike Change in OI Premium
25000 call +115.2 lk shares 80
24900 put +25.8 lk shares 67
Nifty levels
Support 24800
Resistance 25100
Nifty Bank with 20 DMA
Margin Trading Funding
23-Sep-2025 98220cr
Source: NSE
F&O BAN:
OUT OF BAN: HFCL
Ceigall India has been awarded a Letter of Award (LoA) by Greater Mohali Area Development Authority (GMADA) for a road construction project valued at ₹509 crore.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.